Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Explore Which Indices Move This Week and the key drivers behind recent changes. The section offers concise observations to help readers interpret market dynamics.
26,181 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Analysts say SpaceX employees have amassed paper wealth that could, in theory, buy every home in a midsize Texas city...
SpaceX reveals a trillion-dollar revenue forecast, a target far beyond Wall Street estimates and a test of Musk's mos...
A growing family and a high-profile destination wedding are on the horizon for billionaire John Paulson and his fianc...
After years of policy shifts and supply hiccups, a clearer EV roadmap is starting to emerge. This analysis explains w...
As mortgage costs stay elevated and the housing market cools, VNQ provides a stocklike route to real estate income wi...
A breakthrough blood test that screens for 50+ cancers is edging toward real-world use. This article breaks down what...
Alphabet is trading in the mid‑$300s as AI monetization and cloud expansion threaten to carry momentum into the secon...
As AI infrastructure expands, storage demand soars. This article lays out a grounded path for Sandisk's stock by 2027...
A troubling case shows how unauthorized enrollment in life insurance can unfold. Learn how the scheme worked, red fla...
As of mid-2026, JEPI remains a focal point for investors seeking steady monthly income, but the dividend safety check...
Nashville weighs a massive data-center project near the zoo, raising questions about energy bills, taxes, and funding...